Jan 19 |
Accelerate Diagnostics Announces Pricing of Approximately $15 Million Public Offering and Private Placement
|
Jan 16 |
Accelerate Diagnostics announces launch of proposed public offering
|
Jan 16 |
Accelerate Diagnostics Announces Launch of Proposed Public Offering
|
Jan 8 |
Accelerate Diagnostics expects 2023 revenue to fall Y/Y
|
Jan 8 |
Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2023 Results
|
Dec 14 |
Accelerate Diagnostics files to sell common stock, units and pre-funded units
|
Nov 29 |
Accelerate Diagnostics (AXDX) Expands in In Vitro Diagnostics
|
Nov 28 |
Bruker's (BRKR) New Collaboration to Use MALDI Biotyper System
|
Nov 27 |
Accelerate Diagnostics Announces Collaboration for the Use of the Arc™ System in Combination With Bruker´s MALDI Biotyper®
|